Drugs & medicalClass II

Akorn, Inc. recalls Levofloxacin Injection 500mg/20 mL (25 mg/mL), For Intravenous Infusion, packaged in a) 20mL vials and b) 30 mL vials, Rx Only,…

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Read the official notice →
Date
2023-06-07
Country
United States
Brand
Akorn
Product
Levofloxacin Injection 500mg/20 mL (25 mg/mL), For Intravenous Infusion, packaged in a) 20mL vials and b) 30 mL vials, Rx Only,…
Classification
Class II
Units
Nationwide in the USA and Puerto Rico
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Akorn recalls

  1. 2023-02-15
  2. US
    Drugs & medicalClass III

    Akorn, Inc. recalls Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn…

    Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

    FDA · DrugAkorn, Inc.Nationwide in the USA and Puerto RicoOfficial notice →
  3. 2023-01-25
  4. US
  5. 2022-10-05
  6. US
    Drugs & medicalClass II

    Akorn, Inc. recalls Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031, NDC 61748-015-30

    Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

    FDA · DrugAkorn, Inc.USA Nationwide and Puerto RicoOfficial notice →
  7. 2022-09-14
  8. US
    Drugs & medicalClass II

    Akorn, Inc. recalls Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-711-31

    cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

    FDA · DrugAkorn, Inc.USA nationwideOfficial notice →
  9. 2022-09-07
  10. US
    Drugs & medicalClass III

    Akorn, Inc recalls Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials, Rx Only, Sterile, Manufactured for: Akorn, Inc., Lake…

    Failed Impurities/Degradation Specifications: Identification of an unknown impurity at the 12-month stability point.

    FDA · DrugAkorn, IncDistributed Nationwide in the USAOfficial notice →
  11. 2022-08-24
  12. US
All 14 Akorn recalls →

Other drugs & medical recalls in the United States

  1. 2023-06-07
  2. US
    Drugs & medicalClass II

    Maquet Medical Systems USA recalls QUADROX-i Pediatric, Oxygenator used during cardiopulmonary bypass Model Item No. HMO 30000-USA 701070384 HMO 31000-USA 701070388

    1. An accessory may be improperly placed during packaging, causing creases and damage to the accessory's sterile pouch. 2. Product packaging may exhibit holes, cracks, dents, and crushed areas. Both issues may…

    FDA · DeviceMaquet Medical Systems USADomestic distribution nationwide.Official notice →
  3. US
    Drugs & medicalClass II

    Trophy SAS recalls CS¿9600¿is¿an¿extraoral¿system¿intended¿to¿produce¿two-dimensional¿and¿three-dimensional¿digital¿X-ray¿images¿of¿the¿dento-maxilofacial,¿EN…

    Device failed to function as intended and/or failed to conform to their design specifications.

    FDA · DeviceTrophy SASWorldwide DistributionOfficial notice →
  4. US
    Drugs & medicalClass I

    Novis PR, LLC dba Kramer Novis recalls G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal…

    Product mix-up: incorrect product was found inside the G-Supress DX product carton.

    FDA · DrugNovis PR, LLC dba Kramer NovisPuerto RicoOfficial notice →
  5. US
    Drugs & medicalClass III

    New England Life Care, Inc. dba Advanced Compounding… recalls Phenylephrine HCl 20 mg added to 0.9% Sodium Chloride 250mL Bag, Rx Only, Compounded by: Advanced…

    Product Mix up; Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride

    FDA · DrugNew England Life Care, Inc. dba Advanced Compounding…Nationwide in the USA.Official notice →
  6. US
    Drugs & medicalClass II

    Fresenius Medical Care Holdings, Inc. recalls Sodium Chloride 0.9% Injection, USP, 1000 mL bags, 12 bags per carton, Rx only, Fresenius Medical Care North America,…

    Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

    FDA · DrugFresenius Medical Care Holdings, Inc.Product was distributed to 32 clinics in SC, NC and VA.Official notice →
  7. US
    Drugs & medicalClass II

    SSM Health Care St. Louis DBA SSM St. Clare Health Center recalls HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care…

    CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

    FDA · DrugSSM Health Care St. Louis DBA SSM St. Clare Health CenterProduct was distributed in Missouri.Official notice →
See all drugs & medical recalls →